Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced its third significant…
Read More

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced its third significant…
Read More
The pharmaceutical landscape for hereditary angioedema (HAE) is on the cusp of a significant transformation, marked by an unprecedented surge…
Read More
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has delivered two pivotal positive opinions, paving…
Read More
The mystery of why the vast majority of the human population—approximately 90%—favors the right hand has remained one of the…
Read More
The mystery of why the vast majority of the human population favors the right hand has remained one of the…
Read More
The vast expanses of the universe, once thought to be desolate stretches of nothingness, are increasingly being recognized by the…
Read More
Abselion, a pioneering life sciences technology company headquartered in Cambridge, UK, dedicated to streamlining biomolecule quantification, has announced the strategic…
Read More
Vitestro, a pioneering Dutch medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an impressive $70…
Read More
The United Kingdom’s Health Secretary, Wes Streeting, is reportedly considering expanding the national immunisation schedule to include the Meningitis B…
Read More